简体
简体中文
繁體中文

Harbor医疗保健主动型ETF MEDI 深 沪

等待开盘 11-19 09:30:00 美东时间

34.933

-0.297

-0.84%

华盛通华盛通
立即下载
  • 最 高35.31
  • 今 开35.18
  • 成交量 3847股
  • 最 低 34.831
  • 昨 收 35.23
  • 总市值 4279.29万
  • 52周最高 36.54
  • 市盈率 静 --
  • 换手率 0.31%
  • 52周最低 27.50
  • 委 比 0.00%
  • 总股本 122.50万
  • 历史最高 36.54
  • 量 比 0.20
  • 振 幅 1.36%
  • 历史最低 18.9464
  • 每 手 1
  • 风险率 1.77%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • California Water Service Group to Become Watermark Utilities, Reflecting Growth Across Western United States

    California Water Service Group, marking its 100th year, has renamed its holding company to Watermark Utilities to reflect its legacy and growth as a leading water and wastewater provider in the western U.S. The new name will take effect on Nov. 30, 2026, when the company will also ring the NYSE opening bell. CEO Martin Kropelnicki emphasized that the name symbolizes the company's ability to overcome challenges, authenticity, and lasting impact on...

    11-18 21:15

  • New Three-Year Real-World LEQEMBI® Data Presented at CTAD 2026

    Eisai and Biogen announced new three-year real-world findings from the LEADER study, showing LEQEMBI reduced the rate of progression to moderate or severe Alzheimer's disease by 76% compared to a matched cohort. Over 80% of patients remained stable or improved, with 95% estimated to remain in early stages after three years. Amyloid clearance was observed in 77% of patients, and safety profiles were consistent across diverse settings. The findings...

    11-18 16:00

  • MEDIPOST to Discuss Cartistem Clinical Trials and Global Commercialization Strategies

    The latest update is out from MEDIPOST Co., Ltd. ( ($KR:078160) ). MEDIPOST’s r...

    11-18 10:43

  • Biogen’s Diranersen Demonstrates Increasing Clinical Benefit at Two Years in Early Alzheimer’s Disease

    Biogen's Phase 2 CELIA study shows that diranersen, an investigational antisense oligonucleotide targeting tau, slowed clinical decline in early Alzheimer's disease. At two years (Week 96), the 60 mg twice-yearly regimen reduced clinical decline by 38% on the CDR-SB scale, with benefits observed across all doses. The study, presented at the CTAD conference, highlights diranersen's potential to slow disease progression, improve cognitive and funct...

    11-17 21:45

  • Macerich Acquires Oakridge Mall in San Jose, CA for Approximately $250 Million

    Macerich acquired Oakridge Mall in San Jose, CA, for $250 million. The 1.1 million sq. ft. mall attracts 10.8 million annual visits with $866/sq. ft. inline sales. Macerich will fund the purchase with equity, expecting it to be accretive to 2028 FFO and leverage targets. The company plans to enhance retail, dining, and entertainment offerings to boost foot traffic and customer engagement. Oakridge is located in a high-income, supply-constrained r...

    11-16 12:00

  • West Coast Community Bancorp Announces Share Repurchase Program

    West Coast Community Bancorp (WCCB) has approved a $25 million stock repurchase program, valid until December 31, 2028. The program allows the company to repurchase shares in the open market or through private transactions, with timing and quantity determined by market conditions and other factors. CEO Krista Snelling highlighted the program as a strategic use of capital to enhance shareholder value while maintaining flexibility for future growth...

    11-13 21:05

  • STMicroelectronics to host investor call on STM32 pioneering the convergence era

    STMicroelectronics will host an investor webcast on November 18, 2026, focusing on STM32's role in the convergence era. The event, led by Remi El-Ouazzane, President of ST’s MDRF Group, will take place at 3 p.m. CET / 9 a.m. ET, followed by a Q&A session. The webcast will be available live and on-demand at investors.st.com.

    11-12 06:30

  • Magna Unveils 2030 Financial Targets at Investor Day

    Magna International Inc. held an Investor Day in New York City, presenting mid-term financial targets through 2030, including organic sales growth of 2-4% above market, 200+ basis points margin improvement, 15%+ EPS growth, 85%+ FCF conversion, and ROIC >15%. The company expressed confidence in its strategy and plans to repurchase nearly 26 million shares.

    11-11 13:50

  • Mobiquity Technologies and Intercept Music Deliver Breakout Campaign Results, Highlighting Multimillion-Dollar Growth Opportunity

    Mobiquity Technologies and Intercept Music achieved significant success in their joint marketing campaign supporting LOCASH, generating over 8 million streams and substantial audience growth on platforms like Spotify and Pandora. The collaboration lays the groundwork for an exclusive marketing agreement, offering Mobiquity's GrowthOS services to Intercept's network of over 1,000 artists, with potential annual revenue of $3 million to $6 million. ...

    11-11 13:00

  • Kelly Announces Participation in Upcoming Investor Conferences

    Kelly Services will participate in four upcoming investor conferences: the Southwest IDEAS Conference in Dallas on November 18, 2026, the Wells Fargo TMT Summit in California on December 9, 2026, the Sidoti Small-Cap Virtual Conference on December 10, 2026, and the Truist Securities Human Capital Virtual Conference on December 14, 2026. Management will present and hold one-on-one meetings with investors at each event. Kelly’s investor presentatio...

    11-11 12:30